Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand

© 2017 Informa UK Limited, trading as Taylor & Francis Group. Objective: With the advent of the anaplastic lymphoma kinase (ALK) inhibitor, treatment of ALK-positive advanced non-small-cell lung cancer (NSCLC) patients has become more effective while drug costs are still a major concern. This...

Saved in:

書目詳細資料
Main Authors:	Thongprasert S., Permsuwan U.
格式:	雜誌
出版:	2017
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85015768144&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40463
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Sumitra Thongprasert, et al.
出版: (2018)

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Sumitra Thongprasert, et al.
出版: (2018)

Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective
由: Thongprasert,S., et al.
出版: (2015)

Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective
由: Thongprasert S., et al.
出版: (2014)

Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients
由: Sorraritchingchai S., et al.
出版: (2014)

Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
由: Caicun Zhou, et al.
出版: (2020)

Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand
由: Unchalee Permsuwan, et al.
出版: (2020)

Efficacy and tolerability of tropisetron in the prevention of cisplatin-induced nausea and vomiting in advanced non-small cell lung cancer
由: Thongprasert S.
出版: (2014)

Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand
由: Kitiporn Srisam-ang, et al.
出版: (2018)

A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer
由: Sumitra Thongprasert, et al.
出版: (2018)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
由: Akhtari, M, et al.
出版: (2020)

Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
由: Charoentum C., et al.
出版: (2014)

Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
由: Chaiyut Charoentum, et al.
出版: (2018)

Usefulness of the Thai modified functional living index--cancer (T-FLIC) and the Thai modified quality of life index (T-QLI) for advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
由: Charoentum C., et al.
出版: (2014)

An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
由: Chang J.W.-C., et al.
出版: (2014)

Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer
由: Thongprasert S.
出版: (2014)

An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
由: John Wen Cheng Chang, et al.
出版: (2018)

Effects of paclitaxel and carboplatin on quality of life and survival in patients with advanced non-small-cell lung cancer
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

Phase 2 trial of linifanib (ABT-869) in patients with advanced non-small cell lung cancer
由: Tan, E.-H., et al.
出版: (2014)

Paclitaxel and Carboplatin in Combination in the Treatment of Advanced Non-small-cell Lung Cancer (NSCLC) : A Preliminary Study
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
由: Chaiyut Charoentum, et al.
出版: (2018)

Impact of lymph node management on resectable non-small cell lung cancer patients
由: Apichat Tantraworasin, et al.
出版: (2018)

Impact of lymph node management on resectable non-small cell lung cancer patients
由: Apichat Tantraworasin, et al.
出版: (2018)

Impact of lymph node management on resectable non-small cell lung cancer patients
由: Tantraworasin A., et al.
出版: (2017)

A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)
由: Shi Y., et al.
出版: (2014)

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study
由: Krittiya Korphaisarn, et al.
出版: (2022)

Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
由: Huang, Yiqing, et al.
出版: (2023)

Treatment of small cell lung cancer: experience at Maharaj Nakhon Chiang Mai Hospital
由: Thongprasert S., et al.
出版: (2014)

A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)
由: Yuankai Shi, et al.
出版: (2018)

A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)
由: Yuankai Shi, et al.
出版: (2018)

Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital
由: Thongprasert S.
出版: (2014)

Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial
由: Mok T.S.K., et al.
出版: (2014)

Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301
由: Cho B.C.
出版: (2023)